Collectively, these results suggest that indirubin may be a useful as herbal medicine for inducing UCP1 expression and enhance BAT activity (as well as browning of sWAT) via activation of PKA and p38MAPK signaling pathways, thereby potentially in preventing and treating obesity and obesity-associated metabolic diseases. Here, UCP1 is linked to metabolic disease.